miglitol (CID 441314) - BioAssay Data Summary for Compound
.
BioActivity Outcomes:
Active(28)
 
 
Inactive(315)
 
 
Inconclusive(2)
 
 
Unspecified(45)
 
 
Top Targets:
GH31 MGAM SI..(13)
 
 
 
7TM GPCR Srx(10)
 
 
Bcl-2 like(10)
 
 
alkPPc(10)
 
 
NR LBD PPAR(6)
 
 
BioAssay Types:
Screening(207)
 
 
 
 
Confirmatory(106)
 
 
 
 
Literature(68)
 
 
 
 
BioActivity Types:
Potency(58)
 
 
 
 
IC50(53)
 
 
 
 
EC50(9)
 
 
Ki(6)
 
 
SAR
Target summary
Data download

Chemical Probe    Active    Inactive    Inconclusive    Unspecified   

Total Bioassays: 384    Data Row: 390   Total Pages: 8   Display: Page     
Sort: [Click the result table header to sort]
#SubstanceActivityBioAssayTargetLinks
OutcomeTypeValue [μM]
1
[SID103582154]
IC50 0.11Inhibition of rat intestinal brush border membrane sucrase [AID342797, Type: Literature]Sucrase-isomaltase, intestinal [gi:1351132]
View
2
[SID103582154]
Ki 0.13Inhibition of mouse his-tagged ctSI expressed in Sf9 cells assessed as amount of glucose produced using maltose as a substrate after 45 mins by glucose oxidase assay [AID620763, Type: Literature]
View
3
[SID103582154]
Ki 0.148Inhibition of human ntSI expressed in Drosophila S2 cells assessed as amount of glucose produced using maltose as a substrate after 45 mins by glucose oxidase assay [AID620764, Type: Literature]
View
4
[SID103582154]
Ki 0.211Inhibition of mouse his-tagged ctMGAM-N2 expressed in Sf9 cells assessed as amount of glucose produced using maltose as a substrate after 45 mins by glucose oxidase assay [AID620760, Type: Literature]
View
5
[SID103582154]
Ki 0.23Inhibition of mouse his-tagged ctMGAM-N20 expressed in Sf9 cells assessed as amount of glucose produced using maltose as a substrate after 45 mins by glucose oxidase assay [AID620761, Type: Literature]
View
6
[SID103582154]
IC50 0.35Inhibition of human lysosomal alpha-glucosidase [AID342799, Type: Literature]Lysosomal alpha-glucosidase [gi:317373572]
View
7
[SID103582154]
IC50 0.35Inhibition of human lysosomal alpha-glucosidase [AID342799, Type: Literature]Lysosomal alpha-glucosidase [gi:317373572]
View
8
[SID103582154]
IC50 0.35Inhibition of human lysosomal alpha-glucosidase [AID342799, Type: Literature]Lysosomal alpha-glucosidase [gi:317373572]
View
9
[SID103582154]
IC50 0.39Inhibition of rabbit muscle amylo-1,6-glucosidase [AID342805, Type: Literature]Glycogen debranching enzyme [gi:544379]
View
10
[SID103582154]
IC50 0.5Inhibition of sucrase by HPLC [AID466667, Type: Literature]
View
11
[SID103582154]
IC50 0.59Inhibition of Wistar rat small intestine maltase after 30 mins [AID550393, Type: Literature]Lysosomal alpha-glucosidase [gi:81885339]
View
12
[SID103582154]
IC50 1Inhibition of Wistar rat small intestine sucrase after 30 mins [AID550397, Type: Literature]Sucrase-isomaltase, intestinal [gi:1351132]
View
13
[SID103582154]
IC50 1Inhibition of maltase in human Caco-2 cell model system after 2 hrs [AID342811, Type: Literature]Lysosomal alpha-glucosidase [gi:317373572]
View
14
[SID103582154]
IC50 1Inhibition of maltase in human Caco-2 cell model system after 2 hrs [AID342811, Type: Literature]Lysosomal alpha-glucosidase [gi:317373572]
View
15
[SID103582154]
IC50 1Inhibition of maltase in human Caco-2 cell model system after 2 hrs [AID342811, Type: Literature]Lysosomal alpha-glucosidase [gi:317373572]
View
16
[SID103582154]
Ki 1Inhibition of human recombinant N-terminal subunit of maltase-glucoamylase after 60 mins by glucose oxidase assay [AID536212, Type: Literature]Maltase-glucoamylase, intestinal [gi:215274260]
View
17
[SID103582154]
Ki 1Inhibition of human ntMGAM expressed in Drosophila S2 cells assessed as amount of glucose produced using maltose as a substrate after 45 mins by glucose oxidase assay [AID620762, Type: Literature]
View
18
[SID103582154]
IC50 1.2Inhibition of rat intestinal brush border membrane isomaltase [AID342795, Type: Literature]Sucrase-isomaltase, intestinal [gi:1351132]
View
19
[SID103582154]
IC50 1.3Inhibition of rat intestinal brush border membrane maltase [AID342793, Type: Literature]Lysosomal alpha-glucosidase [gi:81885339]
View
20
[SID103582154]
IC50 2Inhibition of lysosomal alpha-glucosidase by HPLC [AID466672, Type: Literature]
View
21
[SID26719889]
Potency 2.2387qHTS Assay for Inhibitors and Activators of Human alpha-Glucosidase From Spleen Homogenate [AID2112, Type: confirmatory]lysosomal alpha-glucosidase preproprotein [Homo sapiens] [gi:119393891]
View
22
[SID26719889]
Potency 2.2387qHTS Assay for Inhibitors and Activators of Human alpha-Glucosidase From Spleen Homogenate [AID2112, Type: confirmatory]lysosomal alpha-glucosidase preproprotein [Homo sapiens] [gi:119393891]
View
23
[SID26719889]
Potency 2.2387qHTS Assay for Inhibitors and Activators of Human alpha-Glucosidase From Spleen Homogenate [AID2112, Type: confirmatory]lysosomal alpha-glucosidase preproprotein [Homo sapiens] [gi:119393891]
View
24
[SID26719889]
Potency 2.2387qHTS Assay for Inhibitors and Activators of Human alpha-Glucosidase Cleavage of Glycogen [AID2100, Type: confirmatory]lysosomal alpha-glucosidase preproprotein [Homo sapiens] [gi:119393891]
View
25
[SID26719889]
Potency 2.2387qHTS Assay for Inhibitors and Activators of Human alpha-Glucosidase Cleavage of Glycogen [AID2100, Type: confirmatory]lysosomal alpha-glucosidase preproprotein [Homo sapiens] [gi:119393891]
View
26
[SID26719889]
Potency 2.2387qHTS Assay for Inhibitors and Activators of Human alpha-Glucosidase Cleavage of Glycogen [AID2100, Type: confirmatory]lysosomal alpha-glucosidase preproprotein [Homo sapiens] [gi:119393891]
View
27
[SID26719889]
Potency 3.5481qHTS Assay for Inhibitors of Human alpha-Glucosidase as a Potential Chaperone Treatment of Pompe Disease [AID1466, Type: confirmatory]lysosomal alpha-glucosidase preproprotein [Homo sapiens] [gi:119393891]
View
28
[SID26719889]
Potency 3.5481qHTS Assay for Inhibitors of Human alpha-Glucosidase as a Potential Chaperone Treatment of Pompe Disease [AID1466, Type: confirmatory]lysosomal alpha-glucosidase preproprotein [Homo sapiens] [gi:119393891]
View
29
[SID26719889]
Potency 3.5481qHTS Assay for Inhibitors of Human alpha-Glucosidase as a Potential Chaperone Treatment of Pompe Disease [AID1466, Type: confirmatory]lysosomal alpha-glucosidase preproprotein [Homo sapiens] [gi:119393891]
View
30
[SID103582154]
IC50 6Inhibition of maltase by HPLC [AID466668, Type: Literature]
View
31
[SID103582154]
IC50 39Inhibition of Wistar rat small intestine isomaltase after 30 mins [AID550395, Type: Literature]Sucrase-isomaltase, intestinal [gi:1351132]
View
32
[SID49681630]
 Primary cell-based high-throughput screening for identification of compounds that antagonize MrgX1 receptor signaling [AID588676, Type: screening]MAS-related GPR member X1 [Homo sapiens] [gi:195969650]
View
33
[SID49681630]
 Primary cell-based high-throughput screening for identification of compounds that antagonize MrgX1 receptor signaling [AID588676, Type: screening]MAS-related GPR member X1 [Homo sapiens] [gi:195969650]
View
34
[SID49681630]
 Single concentration confirmation of uHTS hits from a small molecule antagonists of the APJ receptor via a luminescent beta-arrestin assay [AID2766, Type: screening]APLNR gene product [Homo sapiens] [gi:4885057]
View
35
[SID49681630]
 Single concentration confirmation of uHTS hits from a small molecule antagonists of the APJ receptor via a luminescent beta-arrestin assay [AID2766, Type: screening]APLNR gene product [Homo sapiens] [gi:4885057]
View
36
[SID103582154]
 Antidiabetic activity in obese, insulin resistant C57BL/6J mouse assessed as reduction in blood insulin at 100 mg/kg/day for 4 weeks [AID466853, Type: Literature]
View
37
[SID103582154]
 Antidiabetic activity in obese, insulin resistant C57BL/6J mouse assessed as insulin resistance at 100 mg/kg/day for 4 weeks by HOMA-IR analysis [AID466855, Type: Literature]
View
38
[SID103582154]
 Antidiabetic activity in obese, insulin resistant C57BL/6J mouse assessed as reduction in HbA1c at 100 mg/kg/day for 4 weeks [AID466856, Type: Literature]
View
39
[SID48416282]
 DSSTox (FDAMDD) FDA Maximum (Recommended) Daily Dose Database [AID1195, Type: other]
View
40
[SID49681630]
 uHTS identification of small molecule antagonists of the APJ receptor via a luminescent beta-arrestin assay [AID2521, Type: screening]APLNR gene product [Homo sapiens] [gi:4885057]
View
41
[SID49681630]
 uHTS identification of small molecule antagonists of the APJ receptor via a luminescent beta-arrestin assay [AID2521, Type: screening]APLNR gene product [Homo sapiens] [gi:4885057]
View
42
[SID103582154]
IC50 50Inhibition of lactase by HPLC [AID466669, Type: Literature]
View
43
[SID103582154]
IC50 84Inhibition of human lysosomal beta-glucosidase [AID342801, Type: Literature]Glucosylceramidase [gi:55584151]
View
44
[SID103582154]
IC50 84Inhibition of human lysosomal beta-glucosidase [AID342801, Type: Literature]Glucosylceramidase [gi:55584151]
View
45
[SID103582154]
IC50 200Inhibition of GBA1 by HPLC [AID466670, Type: Literature]
View
46
[SID103582154]
IC50 700Inhibition of pig kidney trehalase assessed as p-nitrophenol release by spectrophotometrically [AID338569, Type: Literature]
View
47
[SID103582154]
IC50 1000Inhibition of GCS by cell-based assay [AID466666, Type: Literature]
View
48
[SID103582154]
IC50 9900Inhibition of baker's yeast alpha-glucosidase by 4-nitrophenolate-based assay [AID441055, Type: Literature]Oligo-1,6-glucosidase IMA1 [gi:1708944]
View
49
[SID103582154]
 Inhibition of Wistar rat small intestine lactase at 1000 uM after 30 mins [AID550399, Type: Literature]Lactase-phlorizin hydrolase [gi:6648054]
View
50
[SID103582154]
 Selectivity ratio of Ki for human ntMGAM to Ki for mouse ctMGAM-N2 [AID620765, Type: Literature]
View